Dr. Ramachandran Srinivasan, MD
Dr. Ramachandran Srinivasan, MD, FACR, completed Medical Diploma/M.B.B.S. in Andhra Medical School, India. He did his internship in Lakewood Hospital, Ohio. He then finished Internal Medicine Residency in Sepulveda, California, followed by a Rheumatology Fellowship at University of California, Los Angeles.
He was awarded board certification as a Diplomate in The American Board of Internal Medicine in 1977. He was elected as Fellow in American College of Rheumatology in 1986 and he held a teaching position as Assistant clinical Professor of Medicine for 25 years at UCLA, Rheumatology division in Medicine Department. He had always been proudly observed by his peers as a credit to the organization for his valuable contributions to rheumatology with his research and publications.
He is a member in Los Angeles County Medical Association, California Medical Association, American College of Physicians, National Psoriasis Foundation, American College of Rheumatology, and American Medical Association.
He is on board as the Medical Director at Complete Care Community Health Center in Monterey Park, California since 1976. He is a consultant Rheumatologist with expertise in treating Rheumatoid arthritis and Autoimmune diseases.
He is the critically acclaimed author of the Amazon bestseller book Dead End Medicine that sheds insight into how and why we have strayed so far off the mark of providing true health care. “Absolutely brilliant. A must read for anyone concerned with the state of health care in the United States TODAY.” – Reviewer
- Medical Diploma/M.B.B.S: University: Andhra Medical School, India – 1968
- Diplomate in American Board of Internal Medicine – 1977
- Fellow in American College of Rheumatology – 1986
- PROFESSIONAL EXPERIENCE:
- Principal Investigator, Monterey Park, CA – 1976 – Present
- Private Practice, Monterey Park Medical Center, Monterey Park, CA – 1976 – Present
- Medical Staff Secretary and Treasurer, Vany Nuys Community Hospital, Van Nuys, CA – 1986 – 1987
- Chief of Staff, Valley Hospital Medical Center, Van Nuys, CA – 1979 – 1980
- Director, Emergency Room Department, Sierra Memorial Hospital, Sun Valley, CA – 1975-1979
- Clinical and Research Fellowship in Rheumatology,UCLA Medical Center, Westwood, CA – 1974 – 1976
- Residency, Internal Medicine, V.A. Hospital, Sepulveda, CA – 1972 – 1974
- Internship, Lakewood Hospital, Ohio
- Director of Emergency Room Department, Sierra Memorial Hospital
- Chief of Staff in Valley Hospital Medical Center, California.
Has been awarded Certification of Completion in:
- Advanced Dermatology Procedures
- Advanced Interventional Pain Management of the Lumbo-sacral spine and extremities
- Stanford University UCSF Vascular Laboratory Interpretation Course
- Lumbar Spinal Injections from the North American Spine Society
Has been certified by the National Procedures Institute for:
- Continuing Medical Education about Echocardiography
- Continuing Medical Education about Colonoscopy
- Continuing Medical Education about Gastroscopy
- Certified by The Marquis Who’s Who Publications Board as Subject of biographical record to have demonstrated outstanding achievement in contributing for the betterment of society.
Previous Hospital Privileges:
- Northridge Hospital Medical Center, Northridge, CA
- Van Nuys Community Hospital, Van Nuys, CA
- Valley Hospital Medical Center, Van Nuys, CA
- Holy Cross Hospital Medical Center, Mission Hills, CA
- Sherman Oaks Community Hospital, Sherman Oaks, CA
- Granada Hills Community Hospital, Granada Hills, CA
- Valley Presbyterian Hospital Medical Center, Van Nuys, CA
- Panorama Community Hospital, Panorama City, CA
- California Medical License
- Hawaii Medical License
- Illinois Medical License
- Nevada Medical License
- Arizona Medical License
- A 24-Week International, Multi-center, Randomized, Parallel-group, Double-blind Trial to Evaluate Metformin Extended Release Monotherapy Compared to Metformin Immediate Release Monotherapy in Adult Subjects with Type 2 Diabetes who have Inadequate Glycemic Control with Diet and Exercise
- A Phase 3, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of XXX 40mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout
- Observational Study of the Use of XXX (XXX) in Adult Hyperuricemic Patients with Gout Refractory to Conventional Therapy
- A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of XXX in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
- Study examining the effect of a decision support tool on interpretation of structured self-monitored blood glucose (SMBG) data in patients with Type 2 diabetes (DECIDE Study)
- “Controlled Double Blind Trial of XXX and XXX on Polymyositis and Dermatomyositis”
- “Prospective Double Blind Evaluations of XXX vs. Placebo in Rheumatoid Arthritis”
- Gold Binding to Lymphocytes in Vivo and in Vitro, UCLA Hospital
- Southern California Rheumatism Society Research Award for original and published research